These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21073436)

  • 1. Recent patents of DNA methylation biomarkers in gastrointestinal oncology.
    Corvalan AH; Maturana MJ
    Recent Pat DNA Gene Seq; 2010 Nov; 4(3):202-9. PubMed ID: 21073436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
    Wong CC; Li W; Chan B; Yu J
    Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
    Cao M; Zhang C; Zhou L
    Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
    Anderson BW; Ahlquist DA
    Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
    Grady WM; Yu M; Markowitz SD
    Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
    Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
    Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation markers in patients with gastrointestinal cancers. Current understanding, potential applications for disease management and development of diagnostic tools.
    Lofton-Day C; Lesche R
    Dig Dis; 2003; 21(4):299-308. PubMed ID: 14752219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPARC and DNA methylation: possible diagnostic and therapeutic implications in gastrointestinal cancers.
    Nagaraju GP; El-Rayes BF
    Cancer Lett; 2013 Jan; 328(1):10-7. PubMed ID: 22939997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
    Vedeld HM; Goel A; Lind GE
    Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
    Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
    Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
    Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
    Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma.
    Tänzer M; Liebl M; Quante M
    Pharmacol Ther; 2013 Nov; 140(2):133-47. PubMed ID: 23791941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic DNA methylation biomarkers in patients with gastrointestinal adenocarcinomas: A systematic review of epigenome-wide studies.
    d'Errico M; Alwers E; Zhang Y; Edelmann D; Brenner H; Hoffmeister M
    Cancer Treat Rev; 2020 Jan; 82():101933. PubMed ID: 31785412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
    Islam F; Tang JC; Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
    Hashimoto Y; Zumwalt TJ; Goel A
    Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic biomarkers in the blood of patients with urological malignancies.
    Ellinger J; Müller SC; Dietrich D
    Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.